Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002385290 | SCV002695689 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-05-23 | criteria provided, single submitter | clinical testing | The c.95delT pathogenic mutation, located in coding exon 2 of the TP53 gene, results from a deletion of one nucleotide at nucleotide position 95, causing a translational frameshift with a predicted alternate stop codon (p.L32Rfs*12). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Myriad Genetics, |
RCV004056948 | SCV004933696 | pathogenic | Li-Fraumeni syndrome 1 | 2024-02-12 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |